Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th
White Bear Lake, Minnesota--(Newsfile Corp. - June 4, 2026) - Envoy Medical® Inc. (NASDAQ: COCH), a hearing health company pioneering fully implanted hearing solutions, today announced that Brent Lucas, CEO of Envoy Medical, will present at the Planet MicroCap Conference on June 16-18, 2026, in Las Vegas, NV. Planet MicroCap Las Vegas 2026 Dates: June 16-18, 2026 Location: Bellagio Hotel & Ca
Biotechnology, Healthcare and Hospitals
2026-06-04 8:30 AM EDT | Envoy Medical, Inc.
AllStar Global Brands Announces FINALIZATION Partnership with Riccione Femminile Calcio
Ontario and Riccione, Italy--(Newsfile Corp. - June 4, 2026) - AllStar Global Brands (OTCID: ALST) ("ASGB") is pleased to announce that an agreement has been finalized to acquire a 60% ownership stake in Riccione Femminile Calcio for €50,000, and will close beginning of July 2026. We are excited to announce significant developments regarding the Calcio Femminile Riccione. As we finalize the acquisition, we anticipate closing the deal in early July, just before the opening
Healthcare and Hospitals, Retail, Health
2026-06-04 8:00 AM EDT | AllStar Health Brands, Inc.
TelyRx to Present at the Small Cap Growth Virtual Investor Conference June 4, 2026
Clearwater, Florida--(Newsfile Corp. - June 3, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that Vanessa Slowey, President and Chief Executive Officer, and John Cascio, Chief Financial Officer, will present live at the Small Cap Growth Virtual Investor Conference hosted by VirtualInvestorConferences.com, o
Healthcare and Hospitals, Health
2026-06-03 8:35 AM EDT | TelyRx
Theralase(R) Lists Warrants on the TSXV
Toronto, Ontario--(Newsfile Corp. - June 3, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, is pleased to announce that the TSX Venture Exchange ("TSXV") has accepted for listing up to 20,399,050 common share p
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-06-03 7:00 AM EDT | Theralase Technologies Inc.
Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)
Winter Park, Florida--(Newsfile Corp. - June 2, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) is thrilled to announce that the powerful new documentary showcasing TNA Wrestling star and former WWE superstar Jeff Sciullo, known to fans worldwide as Elias (or Elijah), is in final editing and racing toward release!
Healthcare and Hospitals, Health
2026-06-02 9:30 AM EDT | Adia Nutrition Inc.
WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of Schedule
WELL has reached its goal of $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada, three calendar quarters ahead of schedule, driven by strong organic growth across WELL Clinics and WELLSTAR together with two accretive acquisitions. WELL had previously guided a $100 million annualized Adjusted EBITDA(1) run-rate by Q1-2027 on approximately $800 million of revenue. The Company has delivered it on approximately $700 million of revenue, implyi
Technology, Computer Software, Healthcare and Hospitals, Health
2026-06-02 6:30 AM EDT | WELL Health Technologies Corp.
Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product
Northvale, New Jersey--(Newsfile Corp. - June 1, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today announced that it has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for a generic drug product in the class of medications called anticoagulants. IQVIA reported branded product sa
Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-01 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Theralase(R) Releases Q1 2026 Financial Statements
Toronto, Ontario--(Newsfile Corp. - May 29, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancer, bacteria and viruses has released the Company's unaudited interim consolidated financial statements for the three-month period ended March
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-05-29 5:04 PM EDT | Theralase Technologies Inc.
CareRx Reports Voting Results from Annual General Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - CareRx Corporation (TSX: CRRX) (the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the nominees listed in the Management Information Circular for the Annual General Meeting of Shareholders held on May 28, 2026 (the "Meeting"), were elected as directors of the Company. In addition, all other resolutions put to vote at the Meeting were passe
2026-05-28 4:15 PM EDT | CareRx Corporation
NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance
Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new patent application (Reference No. P105204NL) covering a new fluid injection technology designed to optimize pressure profiles in needle-free drug delivery systems. The new technology enables a controlled, multi-phase injection profile that delivers the high pressure needed for reli
Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-28 1:43 PM EDT | NuGen Medical Devices Inc.
WELL Health Announces Appointment of Healthcare Executive Derek Clark as Chief Operating Officer
Vancouver, British Columbia--(Newsfi
Technology, Computer Software, Healthcare and Hospitals, Health
2026-05-27 7:00 AM EDT | WELL Health Technologies Corp.
Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry
Winter Park, Florida--(Newsfile Corp. - May 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine and innovative healthcare solutions, today announced that an independent monthly-membership health care sharing ministry — where members pay monthly dues as an alternative to traditional health insurance — now accepts up to three stem cell treatments per client. This expanded coverage provides eligible members with gre
Healthcare and Hospitals, Health
2026-05-26 8:00 AM EDT | Adia Nutrition Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - May 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-26 7:00 AM EDT | Phio Pharmaceuticals Corp.
Discovery Senior Living Certified a Great Place to Work for Fifth Consecutive Year with Strong Employee Engagement and Culture-Driven Performance
Bonita Springs, Florida--(Newsfile Corp. - May 21, 2026) - Discovery Senior Living ("Discovery" or "the Company") and its affiliated companies, one of the nation's largest senior housing operators, announced today that it has once again been officially Certified as a Great Place to Work®, marking the fifth consecutive year the Company has earned the prestigious recognition.
Healthcare and Hospitals, Real Estate, Housing
2026-05-21 2:34 PM EDT | Discovery Senior Living
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
Reno, Nevada--(Newsfile Corp. - May 21, 2026) - Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, announced it has officially commenced trading on the Nasdaq today under the ticker symbol "CNXU." The Company currently has 25,269,996 shares on an issued and outstanding basis and 35,238,222 shares on a fully diluted basis.
Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-21 12:02 PM EDT | Conexeu Sciences Inc.
Veritas Association Management Team Member Denise Herdrich Receives Prestigious John Hinckley Outstanding Service Award
East Dundee, Illinois--(Newsfile Corp. - May 21, 2026) - Veritas Association Management announced that Denise Herdrich, associate director supporting the Society of Cardiovascular Anesthesiologists (SCA), has received the John Hinckley Outstanding Service Award, one of the Society's highest honors recognizing non-physician professionals who have advanced the field of cardiovascular anesthesiology through service and contributions to the specialty. Herdrich was recognized during the SCA
2026-05-21 9:18 AM EDT | Veritas Association Management
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
Winter Park, Florida--(Newsfile Corp. - May 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine, today announced that its subsidiary Adia Med of Winter Park LLC is now actively recruiting participants for two key clinical studies officially listed as "Recruiting" on ClinicalTrials.gov.
Healthcare and Hospitals, Health
2026-05-20 11:58 AM EDT | Adia Nutrition Inc.
Theralase(R) Closes C$4.8 Million Offering
Toronto, Ontario--(Newsfile Corp. - May 20, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses is pleased to announce that it has closed its previously announced brokered private placement offering ("Brokered Offering
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-05-20 11:06 AM EDT | Theralase Technologies Inc.
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
White Bear Lake, Minnesota--(Newsfile Corp. - May 20, 2026) - Envoy Medical® Inc. (NASDAQ: COCH), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of multiple patents across Australia and Europe, as well as the upcoming grant of an additional European patent, further expanding the Company's intellectual property portfolio and reinforcing its position in the cochlear implant i
Biotechnology, Healthcare and Hospitals
2026-05-20 8:30 AM EDT | Envoy Medical, Inc.
Sym Sciences Awarded $50,000 Grant to Advance IND-Ready Cannabinoid Research Platform
New York, New York--(Newsfile Corp. - May 20, 2026) - Sym Sciences announced today that it has been awarded a $50,000 grant from the to support the development of standardized, IND-ready cannabinoid materials for clinical research. The funding will enable Sym Sciences to expand its university research network and accelerate the preparation of regulatory-grade cannabinoid formulations designed for NIH-funded studies. The initiative is focused on streamlining the pathway from product deve
Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-20 8:25 AM EDT | Sym Sciences